gavi.org
14 -GAVI 6.0 MEASUREMENT FRAMEWORK
BOARD MEETING
Hope Johnson
1-2 July 2026, Geneva, Switzerland
•Programmatic ambition linked to anticipated expenditure
• Key assumptions will be regularly tracked to support interpretation
Targets for Gavi 6.0 measurement framework define topline ‘vision of
success’ for Gavi 6.0 strategic objectives with shared Alliance accountability
2
Proposed Gavi 6.0 measurement framework targets informed by Gavi financial forecast
(v23.1) and developed with Alliance Technical Working Group
•8-9 million future deaths averted consistent with Gavi 6.0 IO ,butmay be challenging without full
funding to replenishment ask; Recalibration and current funding context suggest likely to exceed 7.5 million
• 4-5 million additional zero -dose children reached reflecting country realities and funding levels; An
achievable target with distinct framing to avoid confusion with IA2030 target (PPC recommendation)
• A target of 50% of Gavi56 countries reaching IPVc coverage of at least 80% is proposed, with reporting
of disaggregated data on 13 high -risk polio countries (PPC recommendation)
Ambitious targets proposed for health impact and reaching zero -dose children
Supplemented by operationally focused indicators in the Gavi Leap Master Dashboard (GLMD)
•Gavi Leap Master Dashboard provides more timely information about progress on strategy
implementation , with accountabilities for secretariat, partners and countries and reported regularly to
the PPC and Board alongside the Gavi 6.0 measurement framework
Board Meeting, 1- 2 July 2026

1


Board-2026-Mtg -02-Doc 01d
Report to the Board
1-2 July 2026

Subject Consent Agen da – as at 29 June 202 6
Agenda item 01 d
Category For Decision

Section A : Introduction
Three recommendations are being presented to the Board under the Consent Agenda
for consideration. Detailed information on the items can be found in the relevant
Committee papers in a dedicated folder on BoardEffect at:
https://gavi.boardeffect -
uk.diligentoneplatform.com/workrooms/6459/library/files?folderId=325944
Section B : Actions Requested of the Board
The Gavi Alliance Board is requested to consider the following recommendations from
the Gavi Alliance Governance Committee and the Gavi Alliance Programme and
Policy Committee .
Decision One – IRC Chair and Investment Committee Chair appointment s
The Gavi Alliance Governance Committee recommends to the Gavi Alliance Board
that it:
• Appoint Dr. Rana Hajjeh as Independent Review Committee (IRC) Chair for a
3 -year term, effective immediately.
• Appoint Henry Gonzalez, as an Unaffiliated Board Member, effective 1
November 2026 and until 31 October 2029.
• Appoint Henry Gonzalez , as Chair of the Investment Committee, effective 1
November 2026 and until 31 December 2027.
Decision Two – Board Vice Chair Appointment
The Gavi Alliance Governance Committee recommends to the Gavi Alliance Board
that it:
• Appoint Mekdes Daba, as Vice Chair of the Board with individual signatory
authority, effective 1 October 2026 and until 30 September 2028.
• Appoint Mekdes Daba, as Chair of the Governance Committee, effective 1
October 2026 and until 31 December 2027.

1

Board -2026 -Mtg -02-Doc 01a

Gavi Alliance Board Meeting
1-2 July 2026
Global Health Campus, Geneva, Switzerland

Wednesday 1 July : 09. 00-18.00 Board Meeting Day One
Thursday 2 July: 08.30-17.00 Board Meeting Day Two

Quorum: 14
Declarations of Interest
Declarations
Section 5.5 of the Conflicts of Interest Policy for Governance Bodies states “Members involved
in decision-making processes on behalf of Gavi must take appropriate action to ensure
disclosure of Interests and Conflicts of Interest and take the necessary action in respect
thereof.”

Section 6.2 of the Conflicts of Interest Policy for Governance Bodies further states, “The duty
to disclose [in 6.1 above] is a continuing obligation. This means that Members are obliged to
disclose any Interests and/or Conflict of Interest, whenever the Member comes to know the
relevant matter.”

The following declarations were made by members of the Board on their most recent annual
statements .

Board members:
Member
Organisational Interests Financial/Personal/Advisor Int/
Others







Helen Clark , Chair
















None









The Elders (Member); Global
Leadership Foundation (Chair); The
Independent Panel for Pandemic
Preparedness & Response (Co- Chair);
Extractive Industries Transparency
Initiative - EITI (Chair); Partnership for
Maternal, Newborn & Child Health -
PMNCH (Board Chair); &Green Fund
Advisory Board (Chair); Women Deliver
(Board Member); Global Commission
on Drug Policy (Chair); Alliance for
Health Policy & Systems Research
(Chair); Chatham House (President);
INTOSAI -Donor Cooperation
(Ambassador for Supreme Audit
Institution Independence) ;
Gavi -appointed special adviser

1


Board-2026-Mtg- 02-Doc 01c

Report to the Board
1-2 July 2026

Subject No -Objection Consent Decisions
Agenda item 01 c
Category For Information

Since the December 202 5 B oard meeting, five decisions have been circulated
electronically for approval by no- objection consent in line with Sections 11 and 12 of
the Board and Board Committee Operating Procedures.
1) On 8 December 202 5, Board M embers were invited to consider approv al of the
appointment of a Board Member .

No objections were received prior to the end of 18 December 2025, and the
following decision was therefore entered into the record:
In accordance with Section 12.4 of the Board and Board Committee Operating
Procedures, on a no- objection basis, the Gavi Alliance Board:

• Appointed Marit Viktoria Pettersen as Board Member representing Norway
in the donor constituency anchored by Norway, effective 1 January 2026 and
until 31 December 2027
2) On 23 February 202 6, Board Members were invited to consider approval of the
appointment of a Board Member.

No objections were received prior to the end of 5 March 202 6, and the following
decision was therefore entered into the record:
In accordance with Section 12.4 of the Board and Board Committee Operating
Procedures, on a no- objection basis, the Gavi Alliance Board:

• Appointed Monique Vledder as Board Member representing the World Bank,
effective immediately and until her successor is appointed

3) On 27 March 202 6, Board Members were invited to consider approval of the
appointments to the Gavi Board, Committees and Independent Review
Committee (IRC) .

No objections were received prior to the end of 1 0 A pril 2026, and the following
decision was therefore entered into the record:

In accordance with Section 12.4 of the Board and Board Committee Operating
Procedures, on a no- objection basis, the Gavi Alliance Board:

Download: English | French

Download: English | French

Download: English | French

Download: English | French

Download: English | French

Download: English | French

Rotavirus Vaccine Profiles support countries in their decision making process by providing up-to-date and comprehensive information about the Rotavirus vaccines supported by Gavi. The slides include information about availability of prequalified vaccines, efficacy, effectiveness and safety data, estimation of direct cost, storage, transportation and programmatic administration considerations.